HEALTH CANADA

[Franky]

A news release from canada health, I thought it might be interesting for people with lyme disease.

OTTAWA, Oct. 13 - Health Canada is warning consumers and health practitioners not to use the unauthorized intravenous products Bismacine (also known as Chromacine), Dioxychlor (also known as DC-3) and Sulfoxime because they may pose a serious risk to health.
These products have been promoted as an intravenous protocol to treat Lyme disease, a tick-bourne illness.

Additionally, Dioxychlor and Sulfoxime injections have been promoted for the treatment of other health conditions.

Together, Sulfoxime and Dioxychlor are promoted as anti-microbial agents.

Bismacine is not an authorized health product in Canada; however, it has been available for sale from compounding pharmacies in the United States.

Bismacine contains high amounts of bismuth, a heavy metal that is authorized for use in some oral medications to treat Helicobacter pylori, a bacterium that can cause stomach ulcers.

However, using bismuth through injection may result in cardiovascular collapse, kidney failure or death.

There is evidence that Dioxychlor and Sulfoxime, although not authorized by Health Canada, have been purchased by Canadians, in Ontario, Quebec and Nova Scotia, from a U.S. Internet pharmacy.

Bismacine, Dioxychlor or Sulfoxime injections are not recognized naturopathic practices in Canada and they are not used by licensed naturopathic doctors in Canada for the treatment of Lyme disease or any other condition.

All three products are manufactured by American Biologics of Chula Vista, California.